ProfileGDS5678 / 1448225_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 13% 14% 14% 15% 16% 12% 14% 14% 15% 15% 14% 15% 14% 14% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.3509913
GSM967853U87-EV human glioblastoma xenograft - Control 22.3564414
GSM967854U87-EV human glioblastoma xenograft - Control 32.3484914
GSM967855U87-EV human glioblastoma xenograft - Control 42.3328215
GSM967856U87-EV human glioblastoma xenograft - Control 52.3381216
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.3655612
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.3660114
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.3407314
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.3432315
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.352715
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.3412314
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.3378615
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.3458914
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.3455414